SSI2023 –49th Annual Meeting of the Scandinavian Society of Immunology Time: 4.-7.6.2023 Venue: Radisson Blu Marina Palace The SSI2023 meeting brings together immunologists at all Read more
Turku Protein Core is here to boost your protein research! Turku Protein Core (TuProtCore) is a one-stop-shop open-access core facility that helps internal and external Read more
In the context of the 32nd BioCity Symposium (24-25 August 2023) the nineteenth Elias Tillandz prize will be awarded for the best scientific paper published Read more
Comprehensive genetic characterization of cancer tissues was enabled with the advent of next-generation sequencing technologies. These methods helped scientists peer into the cancer genomes, and Read more
New study of Turku Bioscience evaluates tools to detect longitudinal differential expression in proteomics data and introduces a robust approach called RolDE for longitudinal biomarker Read more
Dr. Kalle Rytkönen was granted the title of Docent of Physiology and Functional Genomics by the Faculty of Medicine at the University of Turku. His Read more
The Academy of Finland has taken decisions on the latest round of PROFI funding, a funding scheme aimed at bolstering the research profiles of Finnish universities. University of Turku was granted 12.3 million euros in Read more
We are proud to announce that Johanna Ivaska was awarded Knight, First Class, of the Order of the White Rose of Finland (Suomen Valkoisen Ruusun Read more
Dr. Essi Laajala was awarded second prize for her PhD thesis in the field of diabetes study by the Finnish Diabetes Association. The award was Read more
Responses to targeted cancer therapies are often short-lived, because tumor cells escape the effects of therapy via rewired growth signaling, or due to expansion of Read more
The term for Turku Bioscience and BioCity Turku common board is ending this year. One board member is representing TBC people, and it is now Read more
Last updated on June 25, 2025
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
